{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=QNASL&page=2", "query": { "intervention": "QNASL", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=QNASL&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-09T16:15:45.036Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05292586", "title": "A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone Dipropionate/Formoterol Fumarate", "type": "DRUG" }, { "name": "Beclomethasone Dipropionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1377, "start_date": "2022-08-31", "completion_date": "2024-06-24", "has_results": true, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 91, "location_summary": "Mobile, Alabama • Chandler, Arizona • Encinitas, California + 65 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05292586" }, { "nct_id": "NCT01016223", "title": "A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "Beclomethasone dipropionate", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2010-03", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2012-11-30", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01016223" }, { "nct_id": "NCT00079183", "title": "Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 44, "start_date": "2002-04", "completion_date": "2010-06-10", "has_results": true, "last_update_posted_date": "2017-06-20", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00079183" }, { "nct_id": "NCT01307319", "title": "Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis", "SAR" ], "interventions": [ { "name": "BDP HFA", "type": "DRUG" }, { "name": "Placebo nasal aerosol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 715, "start_date": "2011-03", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2015-02-20", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 45, "location_summary": "Oxford, Alabama • Bell, California • Costa Mesa, California + 40 more", "locations": [ { "city": "Oxford", "state": "Alabama" }, { "city": "Bell", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307319" }, { "nct_id": "NCT04294641", "title": "Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic GVHD" ], "interventions": [ { "name": "Ibrutinib", "type": "DRUG" }, { "name": "ECG", "type": "DIAGNOSTIC_TEST" }, { "name": "PFT's", "type": "DIAGNOSTIC_TEST" }, { "name": "CT", "type": "DIAGNOSTIC_TEST" }, { "name": "Steroid pulse (prednisone)", "type": "DRUG" }, { "name": "Voriconazole", "type": "DRUG" }, { "name": "Posaconazole", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Budesonide", "type": "DRUG" }, { "name": "Beclomethasone", "type": "DRUG" }, { "name": "Filgrastim", "type": "OTHER" }, { "name": "Pegfilgrastim", "type": "OTHER" }, { "name": "Erythropoietin", "type": "OTHER" }, { "name": "Transfusions", "type": "OTHER" }, { "name": "Oral/Skin biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2021-05-10", "completion_date": "2024-10-01", "has_results": true, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 2, "location_summary": "Bethesda, Maryland • St Louis, Missouri", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04294641" }, { "nct_id": "NCT04179461", "title": "Personalized Treatment Algorithms for Difficult-to-treat Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma in Children" ], "interventions": [ { "name": "Cholecalciferol", "type": "DRUG" }, { "name": "antihistamine", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "emollient cream", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Asthma Controller Medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 21, "start_date": "2018-03-16", "completion_date": "2019-10-03", "has_results": true, "last_update_posted_date": "2021-08-20", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04179461" }, { "nct_id": "NCT00659048", "title": "Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2004-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659048" }, { "nct_id": "NCT01016847", "title": "Moderate to Persistent Asthma in the Obese Subject", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Montelukast", "type": "DRUG" }, { "name": "Sugar pill", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 38, "start_date": "2010-01", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2014-11-17", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01016847" }, { "nct_id": "NCT01925950", "title": "Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Gastrointestinal Graft vs Host Disease" ], "interventions": [ { "name": "orBec", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Soligenix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2013-12", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2018-11-01", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 3, "location_summary": "Hackensack, New Jersey • Buffalo, New York • Nashville, Tennessee", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "Buffalo", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925950" }, { "nct_id": "NCT00926575", "title": "Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Gastrointestinal Graft vs Host Disease" ], "interventions": [ { "name": "oral beclomethasone 17,21-dipropionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Soligenix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2009-10", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2013-12-06", "last_synced_at": "2026-09-09T16:15:45.036Z", "location_count": 3, "location_summary": "Buffalo, New York • Durham, North Carolina • Seattle, Washington", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00926575" } ] }